In support of this, Yang et al. showed that CD180 activation inhibits expression of TLR7 and TLR9 in murine macrophages and DCs; notably, patients with SLE also have increased frequencies of CD180-negative macrophages and DCs (Yang et al. 2018a). This evidence concerns the gene TLR9 and systemic lupus erythematosus.